Request Deal Involvement
Ally Bridge Group led a $265m Series B round in Sonoma Biotherapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Morrison Foerster
pr advisors
Canale Communications
or
Principals
bidder
CASDIN CAPITAL
bidder
OCTAGON CAPITAL
bidder
FIDELITY MANAGEMENT & RESEARCH COMPANY
bidder
8VC (EIGHT PARTNERS LLC)
bidder
JANUS HENDERSON INVESTORS
bidder
AVIDITY PARTNERS
bidder
OSAGE VENTURE PARTNERS
bidder
ALEXANDRIA VENTURE INVESTMENTS
bidder
DEEP TRACK CAPITAL
bidder
LILLY ASIA VENTURES
bidder
PIPER SANDLER COMPANIES
bidder
ARROWMARK PARTNERS
bidder
JDRF
bidder
ALLY BRIDGE GROUP
bidder
MIRAE ASSET CAPITAL CO LTD
bidder
NS INVESTMENT
bidder
VERTEX VENTURES
bidder
ARCH VENTURE PARTNERS
bidder
LIFEFORCE CAPITAL
target
SONOMA BIOTHERAPEUTICS
bidder
FRAZIER HEALTHCARE PARTNERS
bidder
GV (GOOGLE VENTURES)
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite